Literature DB >> 9618764

The hyper-IgM (HIM) syndrome.

N Ramesh1, M Seki, L D Notarangelo, R S Geha.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9618764     DOI： 10.1007/bf00792598

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  148 in total

1.  The CD40 ligand expressed by human B cells costimulates B cell responses.

Authors:  A C Grammer; M C Bergman; Y Miura; K Fujita; L S Davis; P E Lipsky
Journal:  J Immunol       Date:  1995-05-15       Impact factor: 5.422

2.  Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome.

Authors:  J Bajorath; K Seyama; S Nonoyama; H D Ochs; A Aruffo
Journal:  Protein Sci       Date:  1996-03       Impact factor: 6.725

3.  Disseminated lymphonodular cryptococcosis in a child with X-linked hyper-IgM immunodeficiency.

Authors:  M D Tabone; G Leverger; J Landman; C Aznar; L Boccon-Gibod; G Lasfargues
Journal:  Pediatr Infect Dis J       Date:  1994-01       Impact factor: 2.129

4.  Hypogammaglobulinemia in mother and son.

Authors:  G N Beall; R F Ashman; M E Miller; C Easwaran; R Raghunathan; J Louie; T Yoshikawa
Journal:  J Allergy Clin Immunol       Date:  1980-06       Impact factor: 10.793

5.  CD40 expression and function in murine B cell ontogeny.

Authors:  E Castigli; F Young; A M Carossino; F W Alt; R S Geha
Journal:  Int Immunol       Date:  1996-03       Impact factor: 4.823

Review 6.  Functions of CD40 and its ligand, gp39 (CD40L).

Authors:  J D Laman; E Claassen; R J Noelle
Journal:  Crit Rev Immunol       Date:  1996       Impact factor: 2.214

7.  Structural organization of the gene for CD40 ligand: molecular analysis for diagnosis of X-linked hyper-IgM syndrome.

Authors:  M Shimadzu; H Nunoi; H Terasaki; R Ninomiya; M Iwata; S Kanegasaka; I Matsuda
Journal:  Biochim Biophys Acta       Date:  1995-01-02

8.  Genomic structure and chromosomal mapping of the murine CD40 gene.

Authors:  J C Grimaldi; R Torres; C A Kozak; R Chang; E A Clark; M Howard; D A Cockayne
Journal:  J Immunol       Date:  1992-12-15       Impact factor: 5.422

9.  Organization of the human CD40L gene: implications for molecular defects in X chromosome-linked hyper-IgM syndrome and prenatal diagnosis.

Authors:  A Villa; L D Notarangelo; J P Di Santo; P P Macchi; D Strina; A Frattini; F Lucchini; C M Patrosso; S Giliani; E Mantuano
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

Review 10.  Defective expression of CD40 ligand on T cells causes "X-linked immunodeficiency with hyper-IgM (HIGM1)".

Authors:  R A Kroczek; D Graf; D Brugnoni; S Giliani; U Korthüer; A Ugazio; G Senger; H W Mages; A Villa; L D Notarangelo
Journal:  Immunol Rev       Date:  1994-04       Impact factor: 12.988
View more
  6 in total

1.  Gastrointestinal Manifestations of Non-AIDS Immunodeficiency.

Authors:  Robert P. McCabe
Journal:  Curr Treat Options Gastroenterol       Date:  2002-02

2.  Induction of functional CD154 (CD40 ligand) in neonatal T cells by cAMP-elevating agents.

Authors:  A Suárez; L Mozo; A Gayo; A Simó; C Gutiérrez
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

Review 3.  Novel Functions of Integrins as Receptors of CD154: Their Role in Inflammation and Apoptosis.

Authors:  Ghada S Hassan; Suzanne Salti; Walid Mourad
Journal:  Cells       Date:  2022-05-25       Impact factor: 7.666

Review 4.  X-linked hyper IgM syndrome.

Authors:  L C Schneider
Journal:  Clin Rev Allergy Immunol       Date:  2000-10       Impact factor: 10.817

5.  Platelet-associated CD40/CD154 mediates remote tissue damage after mesenteric ischemia/reperfusion injury.

Authors:  Peter H Lapchak; Antonis Ioannou; Lakshmi Kannan; Poonam Rani; Jurandir J Dalle Lucca; George C Tsokos
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

6.  Recurrent Gallbladder Hydrops and Sclerosing Cholangitis in 11-Year-Old Male with Hyper IgM Syndrome.

Authors:  Mehri Najafi; Mohammad-Ali Kiani; Kambiz Eftekhari; Asghar Aghamohammadi
Journal:  Iran J Pediatr       Date:  2013-12       Impact factor: 0.364
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.